In European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Computer-aided drug design (CADD) is an emerging field that has drawn a lot of interest because of its potential to expedite and lower the cost of the drug development process. Drug discovery research is expensive and time-consuming, and it frequently took 10-15 years for a drug to be commercially available. CADD has significantly impacted this area of research. Further, the combination of CADD with Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning (DL) technologies to handle enormous amounts of biological data has reduced the time and cost associated with the drug development process. This review will discuss how CADD, AI, ML, and DL approaches help identify drug candidates and various other steps of the drug discovery process. It will also provide a detailed overview of the different in silico tools used and how these approaches interact.
Vemula Divya, Jayasurya Perka, Sushmitha Varthiya, Kumar Yethirajula Naveen, Bhandari Vasundhra
2022-Nov-05
Artificial Intelligence, Computer-Aided Drug Design, Deep Learning, Drug Discovery and Development, Machine Learning
